All Stories

  1. Reply: RE: a cost-effectiveness modeling evaluation comparing a biosimilar follitropin alfa preparation with its reference product for live birth outcome in Germany, Italy, and Spain

    Article • Journal of Medical Economics, February 2019, Taylor & Francis

    Dr Salvatore Gizzo, Dr Klaus Bühler, Joanna Foley

  2. A cost-effectiveness modeling evaluation comparing a biosimilar follitropin alfa preparation with its reference product for live birth outcome in Germany, Italy and Spain

    Article • Journal of Medical Economics, August 2018, Taylor & Francis

    Dr Salvatore Gizzo, Dr Klaus Bühler

  3. Managing infertility with the follitropin alfa prefilled pen injector – patient considerations

    Article • Therapeutics and Clinical Risk Management, June 2015, Taylor & Francis

    Dr Klaus Bühler

  4. Pen systems

    Article • BSI British Standards

    Dr Klaus Bühler